Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7184434rdf:typepubmed:Citationlld:pubmed
pubmed-article:7184434lifeskim:mentionsumls-concept:C0026794lld:lifeskim
pubmed-article:7184434lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7184434lifeskim:mentionsumls-concept:C0681814lld:lifeskim
pubmed-article:7184434pubmed:issue5lld:pubmed
pubmed-article:7184434pubmed:dateCreated1983-8-17lld:pubmed
pubmed-article:7184434pubmed:abstractTextEffects of lysozyme(LY) alone and combination with various antitumor agents were examined using syngeneic tumors mainly Meth-A and MH 134 transplanted into Balb/c and C3H/He mice, respectively. The effects of LY on pulmonary metastases were also examined in BDF1 mice bearing Lewis lung carcinoma (3LL). LY inhibited the growth of Meth-A tumor and enhanced antitumor effects of mitomycin C (MMC). bleomycin (BLM) and 5-fluorouracil (5-FU), LY activated antitumor effects of MMC, BLM and 5-FU on MH 134 tumor, however, LY alone did not show any significant antitumor effect on it. The combination treatments using LY with MMC or 5-FU showed a marked inhibition on pulmonary metastases of 3LL. The pre-treatment of LY inhibited the tumor growth of Sarcoma-180 in ICR mice.lld:pubmed
pubmed-article:7184434pubmed:languagejpnlld:pubmed
pubmed-article:7184434pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7184434pubmed:citationSubsetIMlld:pubmed
pubmed-article:7184434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7184434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7184434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7184434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7184434pubmed:statusMEDLINElld:pubmed
pubmed-article:7184434pubmed:monthMaylld:pubmed
pubmed-article:7184434pubmed:issn0385-0684lld:pubmed
pubmed-article:7184434pubmed:authorpubmed-author:NittaKKlld:pubmed
pubmed-article:7184434pubmed:authorpubmed-author:NishimuraNNlld:pubmed
pubmed-article:7184434pubmed:authorpubmed-author:TaguchiAAlld:pubmed
pubmed-article:7184434pubmed:authorpubmed-author:NakazatoKKlld:pubmed
pubmed-article:7184434pubmed:authorpubmed-author:IrinoOOlld:pubmed
pubmed-article:7184434pubmed:authorpubmed-author:FukawaKKlld:pubmed
pubmed-article:7184434pubmed:issnTypePrintlld:pubmed
pubmed-article:7184434pubmed:volume9lld:pubmed
pubmed-article:7184434pubmed:ownerNLMlld:pubmed
pubmed-article:7184434pubmed:authorsCompleteYlld:pubmed
pubmed-article:7184434pubmed:pagination915-23lld:pubmed
pubmed-article:7184434pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7184434pubmed:meshHeadingpubmed-meshheading:7184434-...lld:pubmed
pubmed-article:7184434pubmed:meshHeadingpubmed-meshheading:7184434-...lld:pubmed
pubmed-article:7184434pubmed:meshHeadingpubmed-meshheading:7184434-...lld:pubmed
pubmed-article:7184434pubmed:meshHeadingpubmed-meshheading:7184434-...lld:pubmed
pubmed-article:7184434pubmed:meshHeadingpubmed-meshheading:7184434-...lld:pubmed
pubmed-article:7184434pubmed:meshHeadingpubmed-meshheading:7184434-...lld:pubmed
pubmed-article:7184434pubmed:meshHeadingpubmed-meshheading:7184434-...lld:pubmed
pubmed-article:7184434pubmed:meshHeadingpubmed-meshheading:7184434-...lld:pubmed
pubmed-article:7184434pubmed:meshHeadingpubmed-meshheading:7184434-...lld:pubmed
pubmed-article:7184434pubmed:year1982lld:pubmed
pubmed-article:7184434pubmed:articleTitle[Experimental studies on antitumor effects of lysozyme].lld:pubmed
pubmed-article:7184434pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7184434pubmed:publicationTypeEnglish Abstractlld:pubmed